How many years can a patient with mid- to late-stage transverse colon cancer live?

The survival period of patients with mid-to-late stage transverse colon cancer needs to be determined based on the treatment situation, but for most cancers, the patient's life expectancy is relatively short after entering the mid-to-late stage.

Transverse colon cancer is very serious when it enters the middle and late stages, and the cancer cells have spread. This situation is usually not treated surgically because surgery cannot completely remove the cancerous tissue. However, if you actively receive radiotherapy or chemotherapy, it can effectively reduce the severity of the disease, relieve clinical symptoms, and prolong survival. At this time, the 5-year survival rate can reach about 60%, but the side effects of drugs need to be minimized during treatment.

If patients with mid- to late-stage transverse colon cancer do not receive treatment after their condition is confirmed, and do not take radiotherapy and chemotherapy to inhibit the proliferation of cancer cells, the tumor will continue to grow, leading to intestinal dysfunction, compressing local tissues and nerves, and causing severe pain. This situation will lead to a serious shortening of the survival period, with a 5-year survival rate of less than 10%, and the patient may lose his life at any time.

Although there is no effective treatment for mid- and late-stage transverse colon cancer, treatment can not only relieve pain but also prolong survival. Therefore, it is necessary to maintain a good attitude and actively receive treatment.